JP2010509287A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2010509287A5 JP2010509287A5 JP2009535731A JP2009535731A JP2010509287A5 JP 2010509287 A5 JP2010509287 A5 JP 2010509287A5 JP 2009535731 A JP2009535731 A JP 2009535731A JP 2009535731 A JP2009535731 A JP 2009535731A JP 2010509287 A5 JP2010509287 A5 JP 2010509287A5
- Authority
- JP
- Japan
- Prior art keywords
- spray
- excess
- nanoparticles
- powder
- drying
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 238000000034 method Methods 0.000 claims 22
- 239000000843 powder Substances 0.000 claims 12
- 239000002245 particle Substances 0.000 claims 11
- 239000002105 nanoparticle Substances 0.000 claims 9
- 238000001035 drying Methods 0.000 claims 8
- 238000002156 mixing Methods 0.000 claims 5
- 239000000203 mixture Substances 0.000 claims 5
- 239000007921 spray Substances 0.000 claims 4
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 claims 2
- DHMQDGOQFOQNFH-UHFFFAOYSA-N Glycine Chemical compound NCC(O)=O DHMQDGOQFOQNFH-UHFFFAOYSA-N 0.000 claims 2
- 102000008100 Human Serum Albumin Human genes 0.000 claims 2
- 108091006905 Human Serum Albumin Proteins 0.000 claims 2
- 229920002472 Starch Polymers 0.000 claims 2
- 239000007789 gas Substances 0.000 claims 2
- 235000019698 starch Nutrition 0.000 claims 2
- 229940032147 starch Drugs 0.000 claims 2
- 239000008107 starch Substances 0.000 claims 2
- 239000000126 substance Substances 0.000 claims 2
- PVNIQBQSYATKKL-UHFFFAOYSA-N tripalmitin Chemical compound CCCCCCCCCCCCCCCC(=O)OCC(OC(=O)CCCCCCCCCCCCCCC)COC(=O)CCCCCCCCCCCCCCC PVNIQBQSYATKKL-UHFFFAOYSA-N 0.000 claims 2
- RKDVKSZUMVYZHH-UHFFFAOYSA-N 1,4-dioxane-2,5-dione Chemical compound O=C1COC(=O)CO1 RKDVKSZUMVYZHH-UHFFFAOYSA-N 0.000 claims 1
- HFQQYIUTYJVYFZ-UHFFFAOYSA-N 4-methylpentyl 2-cyanoprop-2-enoate Chemical compound CC(C)CCCOC(=O)C(=C)C#N HFQQYIUTYJVYFZ-UHFFFAOYSA-N 0.000 claims 1
- WSVLPVUVIUVCRA-KPKNDVKVSA-N Alpha-lactose monohydrate Chemical compound O.O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](CO)O[C@H](O)[C@H](O)[C@H]1O WSVLPVUVIUVCRA-KPKNDVKVSA-N 0.000 claims 1
- 229920000945 Amylopectin Polymers 0.000 claims 1
- 229920000856 Amylose Polymers 0.000 claims 1
- 229920001661 Chitosan Polymers 0.000 claims 1
- FBPFZTCFMRRESA-KVTDHHQDSA-N D-Mannitol Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-KVTDHHQDSA-N 0.000 claims 1
- 229920002307 Dextran Polymers 0.000 claims 1
- 108010010803 Gelatin Proteins 0.000 claims 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 claims 1
- 239000004471 Glycine Substances 0.000 claims 1
- 229920001612 Hydroxyethyl starch Polymers 0.000 claims 1
- KZSNJWFQEVHDMF-BYPYZUCNSA-N L-valine Chemical compound CC(C)[C@H](N)C(O)=O KZSNJWFQEVHDMF-BYPYZUCNSA-N 0.000 claims 1
- 208000019693 Lung disease Diseases 0.000 claims 1
- 229930195725 Mannitol Natural products 0.000 claims 1
- 229920002724 Poly(ethyl cyanoacrylate) Polymers 0.000 claims 1
- 229920002723 Poly(methyl cyanoacrylate) Polymers 0.000 claims 1
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 claims 1
- 229930006000 Sucrose Natural products 0.000 claims 1
- KZSNJWFQEVHDMF-UHFFFAOYSA-N Valine Natural products CC(C)C(N)C(O)=O KZSNJWFQEVHDMF-UHFFFAOYSA-N 0.000 claims 1
- 150000001413 amino acids Chemical class 0.000 claims 1
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 claims 1
- 238000007664 blowing Methods 0.000 claims 1
- 229920001525 carrageenan Polymers 0.000 claims 1
- 239000000679 carrageenan Substances 0.000 claims 1
- 229940113118 carrageenan Drugs 0.000 claims 1
- 235000010418 carrageenan Nutrition 0.000 claims 1
- 239000000969 carrier Substances 0.000 claims 1
- 239000003795 chemical substances by application Substances 0.000 claims 1
- 229940045110 chitosan Drugs 0.000 claims 1
- 239000011248 coating agent Substances 0.000 claims 1
- 238000000576 coating method Methods 0.000 claims 1
- 238000001816 cooling Methods 0.000 claims 1
- 229920001577 copolymer Polymers 0.000 claims 1
- 229960002086 dextran Drugs 0.000 claims 1
- 235000013681 dietary sucrose Nutrition 0.000 claims 1
- 150000002016 disaccharides Chemical class 0.000 claims 1
- 201000010099 disease Diseases 0.000 claims 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 claims 1
- 239000006185 dispersion Substances 0.000 claims 1
- 239000003814 drug Substances 0.000 claims 1
- 229920000159 gelatin Polymers 0.000 claims 1
- 239000008273 gelatin Substances 0.000 claims 1
- 235000019322 gelatine Nutrition 0.000 claims 1
- 235000011852 gelatine desserts Nutrition 0.000 claims 1
- 239000008103 glucose Substances 0.000 claims 1
- -1 glucose and mannitol Chemical class 0.000 claims 1
- 150000004676 glycans Chemical class 0.000 claims 1
- 229940050526 hydroxyethylstarch Drugs 0.000 claims 1
- FZWBNHMXJMCXLU-BLAUPYHCSA-N isomaltotriose Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1OC[C@@H]1[C@@H](O)[C@H](O)[C@@H](O)[C@@H](OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C=O)O1 FZWBNHMXJMCXLU-BLAUPYHCSA-N 0.000 claims 1
- 229960001021 lactose monohydrate Drugs 0.000 claims 1
- 150000002632 lipids Chemical class 0.000 claims 1
- 239000000594 mannitol Substances 0.000 claims 1
- 235000010355 mannitol Nutrition 0.000 claims 1
- 238000005259 measurement Methods 0.000 claims 1
- 150000002772 monosaccharides Chemical class 0.000 claims 1
- 229910052757 nitrogen Inorganic materials 0.000 claims 1
- 229920001542 oligosaccharide Polymers 0.000 claims 1
- 150000002482 oligosaccharides Chemical class 0.000 claims 1
- 239000000546 pharmaceutical excipient Substances 0.000 claims 1
- WTJKGGKOPKCXLL-RRHRGVEJSA-N phosphatidylcholine Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCCCCCCC=CCCCCCCCC WTJKGGKOPKCXLL-RRHRGVEJSA-N 0.000 claims 1
- 229920000747 poly(lactic acid) Polymers 0.000 claims 1
- 229920000058 polyacrylate Polymers 0.000 claims 1
- 229920001610 polycaprolactone Polymers 0.000 claims 1
- 239000004632 polycaprolactone Substances 0.000 claims 1
- 229920002721 polycyanoacrylate Polymers 0.000 claims 1
- 229920000642 polymer Polymers 0.000 claims 1
- 229920000193 polymethacrylate Polymers 0.000 claims 1
- 229920005862 polyol Polymers 0.000 claims 1
- 150000003077 polyols Chemical class 0.000 claims 1
- 229920001282 polysaccharide Polymers 0.000 claims 1
- 239000005017 polysaccharide Substances 0.000 claims 1
- 238000002360 preparation method Methods 0.000 claims 1
- 102000004169 proteins and genes Human genes 0.000 claims 1
- 108090000623 proteins and genes Proteins 0.000 claims 1
- 238000001694 spray drying Methods 0.000 claims 1
- 238000005507 spraying Methods 0.000 claims 1
- 229960004793 sucrose Drugs 0.000 claims 1
- 230000009885 systemic effect Effects 0.000 claims 1
- 229960001947 tripalmitin Drugs 0.000 claims 1
- 239000004474 valine Substances 0.000 claims 1
- UHVMMEOXYDMDKI-JKYCWFKZSA-L zinc;1-(5-cyanopyridin-2-yl)-3-[(1s,2s)-2-(6-fluoro-2-hydroxy-3-propanoylphenyl)cyclopropyl]urea;diacetate Chemical compound [Zn+2].CC([O-])=O.CC([O-])=O.CCC(=O)C1=CC=C(F)C([C@H]2[C@H](C2)NC(=O)NC=2N=CC(=CC=2)C#N)=C1O UHVMMEOXYDMDKI-JKYCWFKZSA-L 0.000 claims 1
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE102006053375A DE102006053375A1 (de) | 2006-11-10 | 2006-11-10 | Verfahren zur Mischung von Pulvern |
| PCT/EP2007/062040 WO2008055951A1 (de) | 2006-11-10 | 2007-11-08 | Verfahren zur mischung von pulvern |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2010509287A JP2010509287A (ja) | 2010-03-25 |
| JP2010509287A5 true JP2010509287A5 (cg-RX-API-DMAC10.html) | 2010-12-16 |
Family
ID=39099637
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2009535731A Pending JP2010509287A (ja) | 2006-11-10 | 2007-11-08 | 粉末を混合する方法 |
Country Status (8)
| Country | Link |
|---|---|
| US (1) | US20100143331A1 (cg-RX-API-DMAC10.html) |
| EP (1) | EP2091518B1 (cg-RX-API-DMAC10.html) |
| JP (1) | JP2010509287A (cg-RX-API-DMAC10.html) |
| KR (1) | KR20090082476A (cg-RX-API-DMAC10.html) |
| CA (1) | CA2669009A1 (cg-RX-API-DMAC10.html) |
| DE (1) | DE102006053375A1 (cg-RX-API-DMAC10.html) |
| TW (1) | TW200829285A (cg-RX-API-DMAC10.html) |
| WO (1) | WO2008055951A1 (cg-RX-API-DMAC10.html) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7611709B2 (en) | 2004-05-10 | 2009-11-03 | Boehringer Ingelheim Pharma Gmbh And Co. Kg | 1,4 O-linked saccharose derivatives for stabilization of antibodies or antibody derivatives |
| EP2296628B1 (en) * | 2008-05-22 | 2014-05-14 | 3M Innovative Properties Company | Process for manufacturing flowable powder drug compositions |
| CA2750711C (en) * | 2009-01-26 | 2015-07-07 | Teva Pharmaceutical Industries Ltd. | Processes for coating a carrier with microparticles |
| US8828544B2 (en) | 2009-04-17 | 2014-09-09 | Commonwealth Scientific And Industrial Research Organisation | Process and apparatus for depositing nanostructured material onto a substrate material |
| KR20140147891A (ko) * | 2012-04-13 | 2014-12-30 | 글락소스미스클라인 인털렉츄얼 프로퍼티 디벨로프먼트 리미티드 | 응집체 입자 |
| BR112015019387A2 (pt) * | 2013-02-15 | 2017-07-18 | Wellmark Int | alimentação mineral - através de formulação |
| PE20212185A1 (es) | 2019-02-18 | 2021-11-11 | Lilly Co Eli | Formulacion de anticuerpos terapeuticos |
| IL327580A (en) * | 2023-10-05 | 2026-06-01 | Nagase Viita Co Ltd | Powder for inhalation |
Family Cites Families (28)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB866038A (en) * | 1957-10-18 | 1961-04-26 | Air Reduction | Polyvinyl acetate powder and method of making the same |
| US3842888A (en) * | 1969-12-15 | 1974-10-22 | Colgate Palmolive Co | Apparatus for introducing ingredients into a spray drying tower |
| GB8622565D0 (en) * | 1986-09-19 | 1986-10-22 | Unilever Plc | Detergent composition |
| JPH0776527A (ja) * | 1993-06-28 | 1995-03-20 | Hayashibara Biochem Lab Inc | 半固形製剤とその製造方法 |
| JPH08302399A (ja) * | 1995-05-09 | 1996-11-19 | Lion Corp | 熱風噴霧乾燥方法 |
| JPH1094726A (ja) * | 1996-09-24 | 1998-04-14 | Tokin Corp | 乾式成形用粉末の製造方法 |
| EP1393721B1 (en) * | 1997-03-20 | 2008-11-26 | Schering Corporation | Dosage form of powder agglomerates |
| AU3764199A (en) * | 1998-04-29 | 1999-11-16 | Genentech Inc. | Spray dried formulations of igf-i |
| GB9827145D0 (en) * | 1998-12-09 | 1999-02-03 | Co Ordinated Drug Dev | Improvements in or relating to powders |
| IT1309592B1 (it) * | 1999-03-05 | 2002-01-24 | Chiesi Farma Spa | Particelle veicolo modificate da utilizzarsi nella preparazione diformulazioni farmaceutiche sotto forma di polimeri per inalazione e |
| JP3363438B2 (ja) * | 2000-05-02 | 2003-01-08 | ビオフェルミン製薬株式会社 | 噴霧乾燥による菌体乾燥物 |
| JP4125512B2 (ja) * | 2000-11-29 | 2008-07-30 | 伊藤ハム株式会社 | 粉末製剤及びその製造方法 |
| CN100400031C (zh) * | 2000-11-29 | 2008-07-09 | 伊藤火腿株式会社 | 粉末制剂及其制备方法 |
| WO2002055101A2 (en) * | 2000-12-21 | 2002-07-18 | Inhale Therapeutic Syst | Storage stable powder compositions of interleukin-4 receptor |
| EP1487417A4 (en) * | 2001-09-17 | 2010-03-17 | Glaxo Group Ltd | DRY POWDER DRUG FORMULATIONS |
| US7202791B2 (en) | 2001-09-27 | 2007-04-10 | Koninklijke Philips N.V. | Method and apparatus for modeling behavior using a probability distrubution function |
| EP1992335A1 (en) * | 2001-11-01 | 2008-11-19 | Nektar Therapeutics | Spray drying methods and compositions thereof |
| JP4015593B2 (ja) * | 2002-09-04 | 2007-11-28 | 株式会社パウレック | 流動層装置 |
| US6962006B2 (en) * | 2002-12-19 | 2005-11-08 | Acusphere, Inc. | Methods and apparatus for making particles using spray dryer and in-line jet mill |
| HUP0500846A3 (en) * | 2002-12-31 | 2008-10-28 | Nektar Therapeutics | Pharmaceutical formulation with an insoluble active agent for pulmonary administration |
| CA2435632A1 (en) * | 2003-07-21 | 2005-01-21 | Warren Hugh Finlay | Formulation of powder containing nanoparticles for aerosol delivery to the lung |
| DE10339197A1 (de) * | 2003-08-22 | 2005-03-24 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | Sprühgetrocknete amorphe Pulver mit geringer Restfeuchte und guter Lagerstabilität |
| US20050191246A1 (en) * | 2003-12-13 | 2005-09-01 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | Powders comprising low molecular dextran and methods of producing those powders |
| DE102004022928A1 (de) * | 2004-05-10 | 2005-12-08 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | Pulver enthaltend neuartige Oligosacharidgemische und Verfahren zu deren Herstellung |
| US7727962B2 (en) * | 2004-05-10 | 2010-06-01 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | Powder comprising new compositions of oligosaccharides and methods for their preparation |
| US7611709B2 (en) * | 2004-05-10 | 2009-11-03 | Boehringer Ingelheim Pharma Gmbh And Co. Kg | 1,4 O-linked saccharose derivatives for stabilization of antibodies or antibody derivatives |
| US7723306B2 (en) * | 2004-05-10 | 2010-05-25 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | Spray-dried powder comprising at least one 1,4 O-linked saccharose-derivative and methods for their preparation |
| DE102006030164A1 (de) * | 2006-06-29 | 2008-01-03 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | Inhalative Pulver |
-
2006
- 2006-11-10 DE DE102006053375A patent/DE102006053375A1/de not_active Withdrawn
-
2007
- 2007-11-08 KR KR1020097012026A patent/KR20090082476A/ko not_active Ceased
- 2007-11-08 US US12/514,104 patent/US20100143331A1/en not_active Abandoned
- 2007-11-08 JP JP2009535731A patent/JP2010509287A/ja active Pending
- 2007-11-08 CA CA002669009A patent/CA2669009A1/en not_active Abandoned
- 2007-11-08 WO PCT/EP2007/062040 patent/WO2008055951A1/de not_active Ceased
- 2007-11-08 EP EP07822344.3A patent/EP2091518B1/de not_active Not-in-force
- 2007-11-09 TW TW096142577A patent/TW200829285A/zh unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Ali et al. | Spray freeze drying for dry powder inhalation of nanoparticles | |
| Cheow et al. | Spray-freeze-drying production of thermally sensitive polymeric nanoparticle aggregates for inhaled drug delivery: effect of freeze-drying adjuvants | |
| Chow et al. | Particle engineering for pulmonary drug delivery | |
| KR101511196B1 (ko) | 아미노산 및/또는 인지질로 부분 또는 완전 코팅된 수불용성 활성제 미립자의 제조를 위한 알코올성 수용액의 분무 건조법 | |
| Manu et al. | Spray drying in pharmaceutical industry: A review | |
| CA2113901C (en) | Preparation of microparticles | |
| Wang et al. | A comparison between spray drying and spray freeze drying for dry powder inhaler formulation of drug-loaded lipid–polymer hybrid nanoparticles | |
| JP4077803B2 (ja) | 多孔質アパタイト粒状物を用いる安定で、味覚をマスクした製薬剤形 | |
| ES2267637T3 (es) | Revestimiento de pequeñas particulas. | |
| US20060093678A1 (en) | Methods for making pharmaceutical formulations comprising deagglomerated microparticles | |
| JP5575667B2 (ja) | 薬物の投与のためのナノ粒子キャリア及びその製造方法 | |
| JP2003509361A (ja) | 微細粒子を得る方法 | |
| JP2001526207A (ja) | マイクロ粒子およびそれらの治療または診断使用 | |
| JP2004537401A (ja) | 疎水性薬物の微粉砕方法 | |
| Kondo et al. | Design of sustained release fine particles using two-step mechanical powder processing: particle shape modification of drug crystals and dry particle coating with polymer nanoparticle agglomerate | |
| Bohr et al. | Nanoembedded microparticles for stabilization and delivery of drug-loaded nanoparticles | |
| Noviendri et al. | Fabrication of fucoxanthin-loaded microsphere (F-LM) by two steps double-emulsion solvent evaporation method and characterization of fucoxanthin before and after microencapsulation | |
| Binesh et al. | Microencapsulation: spray drying | |
| Bowey et al. | Systemic and mucosal delivery of drugs within polymeric microparticles produced by spray drying | |
| CN101721375A (zh) | 胰岛素缓释微米球组合物及其制备方法 | |
| KR20090082476A (ko) | 분말의 혼합 방법 | |
| Kho et al. | Optimizing aerosolization efficiency of dry-powder aggregates of thermally-sensitive polymeric nanoparticles produced by spray-freeze-drying | |
| Albetawi | Current research on spray-dried chitosan nanocomposite microparticles for pulmonary drug delivery | |
| CN101744772A (zh) | 一种制备兽用药物缓释微粒的方法 | |
| CN106560176B (zh) | 一种载灯盏花素纳米结晶的长效缓释微粒及其制备方法 |